Literature DB >> 9855289

BAPTA-AM blocks both voltage-gated and Ca2+-activated K+ currents in cultured bovine chromaffin cells.

F J Urbano1, W Buño.   

Abstract

The effects of the membrane permeant Ca2+ chelator BAPTA-AM on voltage-gated Na+, Ca2+, K+ (I(Na), I(Ca) I(K), respectively) and Ca2+-activated K+ (I(KCa)) currents in cultured bovine chromaffin cells were investigated using the whole-cell patch-clamp technique. Superfusion with BAPTA-AM (50 microM) induced a rapid (< 60 s) and reversible block of both I(KCa) and I(K) (approximately 50%), without affecting either I(Ca) or I(Na). Preincubation with BAPTA-AM (50 microM, 30 min) or cell loading with the nonpermeable active form of BAPTA (10 mM in the pipette solution) permanently blocked I(KCa). BAPTA-AM superfusion (50 microM) also blocked I(K) (approximately 53%) after BAPTA-loading or BAPTA-AM preincubation. In conclusion, we show a fast and reversible block of I(KCa) and I(K) by BAPTA-AM, acting directly on K+ channels before it operates as a Ca2+ chelator, in cultured bovine chromaffin cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9855289     DOI: 10.1097/00001756-199810260-00013

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  The role of Ca2+ stores in the muscarinic inhibition of the K+ current IK(SO) in neonatal rat cerebellar granule cells.

Authors:  D F Boyd; J A Millar; C S Watkins; A Mathie
Journal:  J Physiol       Date:  2000-12-01       Impact factor: 5.182

2.  Antiangiogenic VEGF165b Regulates Macrophage Polarization via S100A8/S100A9 in Peripheral Artery Disease.

Authors:  Vijay Chaitanya Ganta; Min Choi; Charles R Farber; Brian H Annex
Journal:  Circulation       Date:  2019-01-08       Impact factor: 29.690

3.  Pericellular Ca(2+) recycling potentiates thrombin-evoked Ca(2+) signals in human platelets.

Authors:  Stewart O Sage; Nicholas Pugh; Richard W Farndale; Alan G S Harper
Journal:  Physiol Rep       Date:  2013-10-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.